Article Type
Original Research
Published
This article examines the real-world safety profile of aliaxin fillers fillers derived from worldwide post-marketing surveillance data
Tag: safety
Article Type
Original Research
Published
This study aimed to evaluate the effectiveness of tildrakizumab in treating moderate-to-severe psoriasis within a real-world setting over a 52-week period in Portugal.
Article Type
Review
Published
This multicentre, retrospective study evaluates the efficacy and safety of risankizumab in a population of psoriatic patients with palmoplantar involvement over a 52-week treatment period.
Article Type
Review
Published
This narrative review summarizes the current literature regarding the mechanism of action of tofacitinib, data from registrational trials, emerging real-world evidence, and an overview of the most recent safety evidence. The authors explore evolving treatment paradigms and also present a brief overview of the next generation of JAK inhibitors in the pipeline.
Article Type
Review
Published
